logo
Select company
Select metric
-18.51%Buyback Yield
VS
Market
12
Sector
30
Industry
37
History
38
$ 14.01Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-18.51%$ 666.87M$ 123.43M
3/31/2025-52.59%$ 234.58M$ 123.37M
12/31/2024-30.03%$ 410.86M$ 123.37M
9/30/2024-9.65%$ 1.26B$ 122.08M
6/30/20240%$ 700.23M$ 34K
3/31/2024-23.96%$ 590.62M$ 141.51M
12/31/2023-29.27%$ 531.56M$ 155.59M
9/30/2023-34.57%$ 450M$ 155.59M
6/30/2023-20.21%$ 891.53M$ 180.17M
3/31/2023-7.13%$ 542.12M$ 38.67M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) Buyback Yield stands at -15.93%.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average Buyback Yield has been -14.69%.
  • The median Buyback Yield for PHATHOM PHARMACEUTICALS INC during this period was -9.18%
  • PHATHOM PHARMACEUTICALS INC reached its highest Buyback Yield over the past 5 years at 0%.
  • The lowest Buyback Yield recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe -52.59%

PHATHOM PHARMACEUTICALS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
GYRE : GYRE THERAPEUTICS INC -4.01%ANAB : ANAPTYSBIO INC -6.87%NAGE : NIAGEN BIOSCIENCE INC -1.56%CRMD : CORMEDIX INC -14.38%TBPH : THERAVANCE BIOPHARMA INC 0.33%ZYME : ZYMEWORKS INC 2.28%URGN : UROGEN PHARMA LTD -1.8%ZVRA : ZEVRA THERAPEUTICS INC -10.44%XNCR : XENCOR INC -39.31%KURA : KURA ONCOLOGY INC -0.71%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for PHATHOM PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 191.47M ]) / Market Cap [ $ 1.2B ]
(=) Buyback Yield [ -15.93% ]

PHAT - Buyback Yield, Last 5 years

-52.59%

Minimum

Mar 31, 2025

0%

Maximum

Jun 30, 2024

-14.69%

Average

-9.18%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.46%
average0.64%
median0.01%
std2.71%